Age (years) | Device | Relief | Prevention | ||
0–2 | MDI spacer+ face mask2-a | Salbutamol 200 μg 6 hourly (1 mg 3 hourly) | Beclomethasone 50−200 μg (600 μg) 12 hourly | ||
Terbutaline 250 μg 6 hourly (2.5 mg 3 hourly) | Fluticasone 25−100 μg (250 μg) 12 hourly | ||||
Ipratropium bromide 125 μg 6 hourly (250 μg 6 hourly)2-b | Budesonide 50−200 μg (600 μg) 12 hourly | ||||
Cromoglycate 5−10 mg 6−8 hourly2-c | |||||
Nebuliser | Salbutamol 2.5 mg 6 hourly (3 hourly) | Budesonide up to 1000 μg 12 hourly | |||
Terbutaline 5 mg 6 hourly (3 hourly) | Cromoglycate 20 mg 6−8 hourly2-c | ||||
Ipratropium bromide 250 μg 6 hourly2-b | |||||
>2–5 | MDI+spacer | Salbutamol 200 μg 6 hourly (1 mg 3 hourly) | Cromoglycate 10 mg 6−8 hourly | ||
Terbutaline 500 μg 6 hourly (2.5 mg 3 hourly) | Beclomethasone 50−200 μg (800 μg) 12 hourly | ||||
Budesonide 50−200 μg (600 μg) 12 hourly | |||||
Fluticasone 25−100 μg (250 μg) 12 hourly | |||||
Nebuliser | Salbutamol 2.5−5 mg 6 hourly (3 hourly) | Budesonide up to 1000 μg 12 hourly | |||
Terbutaline 5−10 mg 6 hourly (3 hourly) |